Related Experiment Video
Updated: Nov 9, 2025

08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
7.8K
Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD. Authors'
Sara Rundquist1, Michael C Sachs2, Carl Eriksson1,2
1Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Alimentary Pharmacology & Therapeutics
|April 8, 2021
Abstract
No abstract available in PubMed .

